company background image
4009 logo

Middle East Healthcare SASE:4009 Stok Raporu

Son Fiyat

ر.س71.70

Piyasa Değeri

ر.س6.6b

7D

-0.3%

1Y

0.1%

Güncellenmiş

05 Nov, 2024

Veri

Şirket Finansalları +

Middle East Healthcare Company

SASE:4009 Stok Raporu

Piyasa değeri: ر.س6.6b

4009 Stoklara Genel Bakış

Bir sağlık hizmeti sağlayıcısı olan Middle East Healthcare Company, Orta Doğu ve Kuzey Afrika'da Saudi German Hospital adı altında bir hastane ağının sahibi ve işletmecisidir.

Middle East Healthcare Company Rakipler

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Middle East Healthcare
Tarihsel hisse senedi fiyatları
Güncel Hisse Fiyatıر.س71.70
52 Haftanın En Yüksek Seviyesiر.س134.40
52 Haftanın En Düşük Seviyesiر.س61.50
Beta0.39
11 Aylık Değişim3.02%
3 Aylık Değişim5.44%
1 Yıllık Değişim0.14%
33 Yıllık Değişim105.44%
5 Yıllık Değişim181.18%
Halka arzdan bu yana değişim0.28%

Son Haberler & Güncellemeler

Investors Will Want Middle East Healthcare's (TADAWUL:4009) Growth In ROCE To Persist

Sep 24
Investors Will Want Middle East Healthcare's (TADAWUL:4009) Growth In ROCE To Persist

Middle East Healthcare Company (TADAWUL:4009) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Aug 09
Middle East Healthcare Company (TADAWUL:4009) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Recent updates

Investors Will Want Middle East Healthcare's (TADAWUL:4009) Growth In ROCE To Persist

Sep 24
Investors Will Want Middle East Healthcare's (TADAWUL:4009) Growth In ROCE To Persist

Middle East Healthcare Company (TADAWUL:4009) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Aug 09
Middle East Healthcare Company (TADAWUL:4009) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Middle East Healthcare Company's (TADAWUL:4009) Price In Tune With Earnings

Jul 18
Middle East Healthcare Company's (TADAWUL:4009) Price In Tune With Earnings

There's Been No Shortage Of Growth Recently For Middle East Healthcare's (TADAWUL:4009) Returns On Capital

May 30
There's Been No Shortage Of Growth Recently For Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Middle East Healthcare Company Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

May 09
Middle East Healthcare Company Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

If EPS Growth Is Important To You, Middle East Healthcare (TADAWUL:4009) Presents An Opportunity

Apr 29
If EPS Growth Is Important To You, Middle East Healthcare (TADAWUL:4009) Presents An Opportunity

Why Investors Shouldn't Be Surprised By Middle East Healthcare Company's (TADAWUL:4009) 27% Share Price Plunge

Apr 02
Why Investors Shouldn't Be Surprised By Middle East Healthcare Company's (TADAWUL:4009) 27% Share Price Plunge

There's Reason For Concern Over Middle East Healthcare Company's (TADAWUL:4009) Massive 40% Price Jump

Feb 11
There's Reason For Concern Over Middle East Healthcare Company's (TADAWUL:4009) Massive 40% Price Jump

Returns On Capital At Middle East Healthcare (TADAWUL:4009) Have Stalled

Feb 08
Returns On Capital At Middle East Healthcare (TADAWUL:4009) Have Stalled

Should You Be Adding Middle East Healthcare (TADAWUL:4009) To Your Watchlist Today?

Jan 18
Should You Be Adding Middle East Healthcare (TADAWUL:4009) To Your Watchlist Today?

Middle East Healthcare Company's (TADAWUL:4009) Revenues Are Not Doing Enough For Some Investors

Dec 28
Middle East Healthcare Company's (TADAWUL:4009) Revenues Are Not Doing Enough For Some Investors

Middle East Healthcare (TADAWUL:4009) Will Want To Turn Around Its Return Trends

Sep 26
Middle East Healthcare (TADAWUL:4009) Will Want To Turn Around Its Return Trends

Some Investors May Be Worried About Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Jun 28
Some Investors May Be Worried About Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Investors Could Be Concerned With Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Mar 30
Investors Could Be Concerned With Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Capital Allocation Trends At Middle East Healthcare (TADAWUL:4009) Aren't Ideal

Sep 20
Capital Allocation Trends At Middle East Healthcare (TADAWUL:4009) Aren't Ideal

Calculating The Intrinsic Value Of Middle East Healthcare Company (TADAWUL:4009)

Jun 14
Calculating The Intrinsic Value Of Middle East Healthcare Company (TADAWUL:4009)

Returns On Capital At Middle East Healthcare (TADAWUL:4009) Paint A Concerning Picture

Apr 18
Returns On Capital At Middle East Healthcare (TADAWUL:4009) Paint A Concerning Picture

Here's What's Concerning About Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Aug 10
Here's What's Concerning About Middle East Healthcare's (TADAWUL:4009) Returns On Capital

Middle East Healthcare (TADAWUL:4009) Will Will Want To Turn Around Its Return Trends

Mar 29
Middle East Healthcare (TADAWUL:4009) Will Will Want To Turn Around Its Return Trends

An Intrinsic Calculation For Middle East Healthcare Company (TADAWUL:4009) Suggests It's 28% Undervalued

Mar 03
An Intrinsic Calculation For Middle East Healthcare Company (TADAWUL:4009) Suggests It's 28% Undervalued

Are Middle East Healthcare's (TADAWUL:4009) Statutory Earnings A Good Guide To Its Underlying Profitability?

Feb 10
Are Middle East Healthcare's (TADAWUL:4009) Statutory Earnings A Good Guide To Its Underlying Profitability?

Weak Financial Prospects Seem To Be Dragging Down Middle East Healthcare Company (TADAWUL:4009) Stock

Jan 23
Weak Financial Prospects Seem To Be Dragging Down Middle East Healthcare Company (TADAWUL:4009) Stock

If You Had Bought Middle East Healthcare's (TADAWUL:4009) Shares Three Years Ago You Would Be Down 38%

Jan 05
If You Had Bought Middle East Healthcare's (TADAWUL:4009) Shares Three Years Ago You Would Be Down 38%

Should You Be Impressed By Middle East Healthcare's (TADAWUL:4009) Returns on Capital?

Dec 18
Should You Be Impressed By Middle East Healthcare's (TADAWUL:4009) Returns on Capital?

Calculating The Fair Value Of Middle East Healthcare Company (TADAWUL:4009)

Nov 30
Calculating The Fair Value Of Middle East Healthcare Company (TADAWUL:4009)

Hissedar Getirileri

4009SA HealthcareSA Pazar
7D-0.3%-1.3%1.1%
1Y0.1%3.2%-9.2%

Getiri vs. Endüstri: 4009 geçen yıl % 3.2 oranında getiri sağlayan SA Healthcare sektörünün gerisinde kaldı.

Getiri vs Piyasa: 4009 geçen yıl % -9.2 oranında getiri sağlayan SA Piyasasını aştı.

Fiyat Oynaklığı

Is 4009's price volatile compared to industry and market?
4009 volatility
4009 Average Weekly Movement5.4%
Healthcare Industry Average Movement4.4%
Market Average Movement4.4%
10% most volatile stocks in SA Market7.3%
10% least volatile stocks in SA Market2.7%

İstikrarlı Hisse Senedi Fiyatı: 4009 son 3 ayda önemli bir fiyat oynaklığı yaşamadı.

Zaman İçindeki Volatilite: 4009 'nin haftalık oynaklığı ( 5% ) son bir yıldır istikrarlı seyretti.

Şirket Hakkında

KurulduÇalışanlarCEOWeb sitesi
1988n/aAhmed Mohamed Al-Atrissaudigermanhealth.com

Bir sağlık hizmeti sağlayıcısı olan Middle East Healthcare Company, Orta Doğu ve Kuzey Afrika'da Saudi German Hospital adı altında bir hastane ağının sahibi ve işletmecisidir. Ayrıca tıp ve eğitim merkezleri, rehabilitasyon merkezleri, fizyoterapi, eczaneler, laboratuvarlar ve radyoloji merkezlerini işletmekte, yönetmekte ve bakımını yapmaktadır. Şirket ayrıca tıbbi projeler inşa etmek ve sergiler kurmak, yönetmek, inşa etmek ve düzenlemek için arazi satın almaktadır.

Middle East Healthcare Company Temel Bilgiler Özeti

Middle East Healthcare'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
4009 temel i̇stati̇sti̇kler
Piyasa değeriر.س6.60b
Kazançlar(TTM)ر.س211.36m
Gelir(TTM)ر.س2.85b

31.2x

F/K Oranı

2.3x

P/S Oranı

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
4009 gelir tablosu (TTM)
Gelirر.س2.85b
Gelir Maliyetiر.س1.96b
Brüt Kârر.س894.93m
Diğer Giderlerر.س683.57m
Kazançlarر.س211.36m

Son Raporlanan Kazançlar

Sep 30, 2024

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)2.30
Brüt Marj31.36%
Net Kâr Marjı7.41%
Borç/Özkaynak Oranı146.2%

4009 uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün